INNOVANCE PFA-200 System*Fast and reliable platelet dysfunction detection

The INNOVANCE® PFA-200 System* provides automated assessment for inherited, acquired, or drug-induced platelet dysfunction. It measures the process of primary hemostasis and aids in the rapid detection of platelet dysfunction. Through flow technology, the system provides a realistic hemodynamic environment for the measurement of primary hemostasis.

  • Screens platelet function in patients with impaired primary hemostasis, such as von Willebrand disease1
  • Provides excellent sensitivity for congenital platelet dysfunction, such as Glanzmann thrombasthenia
  • Verifies efficacy of desmopressin acetate (DDAVP) therapy in presurgical patients2
  • Assesses platelet dysfunction caused by aspirin
  • Evaluates platelet dysfunction in multiple clinical settings, such as presurgical screening, high-risk pregnancy and menorrhagia
  • Detects platelet P2Y12-receptor blockades in patients undergoing therapy with P2Y12-receptor antagonists